X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-13 | MLYS | Samsara Biocapital Gp, LLC | 10% | P - Purchase | $13.50 | +600,000 | 5,674,916 | +12% | +$8,100,000 | ||||||
2024-11-26 | NGNE | Samsara Biocapital Gp, LLC | 10% | P - Purchase | $25.83 | +48,770 | 1,717,127 | +3% | +$1,259,623 | ||||||
2024-05-30 | CRGX | Samsara Biocapital Gp, LLC | 10% | P - Purchase | $17.00 | +294,000 | 4,415,689 | +7% | +$4,998,000 | ||||||
2024-02-12 | MLYS | Samsara Biocapital Gp, LLC | 10% | P - Purchase | $13.50 | +555,555 | 5,074,916 | +12% | +$7,499,993 | ||||||
| D | 2023-11-14 | CRGX | Samsara Biocapital Gp, LLC | 10% | P - Purchase | $15.00 | +666,666 | 4,121,689 | +19% | +$9,999,990 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |